GlassScriptPhysician profile
William Jeffrey Foxx
NPI 1801891353
$884.91
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $46.90 · 2021: $518 · 2022: $63.68 · 2023: $27.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.81 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.42 | 2021 | |
| Antares Pharma, INC. | $63.68 | 2022 | |
| Janssen Pharmaceuticals, INC | $48.27 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.20 | 2021 | |
| Novartis Pharmaceuticals Corporation | $45.97 | 2019 | |
| Welch Allyn | $44.55 | 2021 | |
| Lilly USA, LLC | $40.03 | 2019 | |
| Merck Sharp & Dohme LLC | $37.46 | 2019-2021 | |
| Novo Nordisk INC | $29.34 | 2021 | |
| Genentech USA, INC. | $26.83 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.52 | 2020-2021 | |
| Pfizer INC. | $24.74 | 2021-2023 | |
| Esperion Therapeutics, INC. | $17.86 | 2021 | |
| Amgen INC. | $17.76 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $16.30 | 2019 | |
| Amneal Pharmaceuticals LLC | $14.70 | 2023 | Unithroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.02 | 2021 | |
| Minerva Surgical, INC | $13.93 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.87 | 2021 | |
| Glaxosmithkline, LLC. | $12.26 | 2020 | |
| Insulet Corporation | $11.95 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $11.63 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.55 | 2021 | |
| Medtronic USA, INC. | $10.81 | 2019 | |
| Vivus LLC | $7.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Foxx listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.